omeprazole sulfide has been researched along with Helicobacter Infections in 1 studies
*Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kühler, TC; Larsson, H; Mellgârd, B; Shcherbuchin, V; Sjöström, JE; Swanson, M | 1 |
1 other study(ies) available for omeprazole sulfide and Helicobacter Infections
| Article | Year |
|---|---|
Structure-activity relationship of 2-[[(2-pyridyl)methyl]thio]-1H- benzimidazoles as anti Helicobacter pylori agents in vitro and evaluation of their in vivo efficacy.
Topics: Animals; Anti-Bacterial Agents; Benzimidazoles; Female; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Proton Pump Inhibitors; Pyridines; Rats; Structure-Activity Relationship | 1998 |